References
- Sacerdote P, Franchi S, Moretti S, et al. Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain. J Neuroimmune Pharmacol. 2013;8:202–211.
- Liou JT, Lee CM, Day YJ. The immune aspect in neuropathic pain: role of chemokines. Acta Anaesthesiol Taiwanica. 2013;51:127–132.
- Rescher U, Gerke V. Annexins – unique membrane binding proteins with diverse functions. J Cell Sci. 2004;117:2631–2639.
- Tsai JH, Lin YL, Cheng YC, et al. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma. Mod Pathol. 2015;28:268–278.
- Avenali L, Narayanan P, Rouwette T, et al. Annexin A2 regulates TRPA1-dependent nociception. J Neurosci. 2014;34:14506–14516.
- Pieretti S, Di Giannuario A, De Felice M, et al. Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides. Pain. 2004;109:52–63.
- Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol. 2005;6:449–461.
- Lu Y, Ni S, He LN, et al. Annexin A10 is involved in the development and maintenance of neuropathic pain in mice. Neurosci Lett. 2016;631:1–6.
- Shimizu T, Kasamatsu A, Yamamoto A, et al. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways. PloS One. 2012;7:e45510.
- Widmann C, Gibson S, Jarpe MB, et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79:143–180.
- Obata K, Noguchi K. MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci. 2004;74:2643–2653.
- Cao JL, Ruan JP, Ling DY, et al. Activation of peripheral ephrinBs/EphBs signaling induces hyperalgesia through a MAPKs-mediated mechanism in mice. Pain. 2008;139:617–631.
- Popiolek-Barczyk K, Makuch W, Rojewska E, et al. Inhibition of intracellular signaling pathways NF-kappaB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia. Pharmacol Rep. 2014;66:845–851.
- Kawasaki Y, Xu ZZ, Wang X, et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med. 2008;14:331–336.
- Sacerdote P, Mussano F, Franchi S, et al. Biological components in a standardized derivative of bovine colostrum. J Dairy Sci. 2013;96:1745–1754.
- Zhang Q, Cao DL, Zhang ZJ, et al. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice. J Neuroinflamm. 2016;13:183.
- Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107.
- Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88.
- Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63.
- Imai Y, Kohsaka S. Structure of rat annexin V gene and molecular diversity of its transcripts. Eur J Biochem/FEBS. 1995;232:327–334.
- Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82:331–371.
- Rosengarth A, Luecke H. A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J Mol Biol. 2003;326:1317–1325.
- Song XJ, Zheng JH, Cao JL, et al. EphrinB–EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats. Pain. 2008;139:168–180.
- Xin WJ, Gong QJ, Xu JT, et al. Role of phosphorylation of ERK in induction and maintenance of LTP of the C-fiber evoked field potentials in spinal dorsal horn. J Neurosci Res. 2006;84:934–943.
- Cook SJ, Lockyer PJ. Recent advances in Ca(2+)-dependent Ras regulation and cell proliferation. Cell Calcium. 2006;39:101–112.